Bordetella pertussis produces a calmodulin-dependent adenylate cyclase (AC) which acts as a toxin capable of penetrating eukaryotic cells and generating high levels of intracellular cyclic AMP. Transfer of target cells into B. pertussis AC-free medium leads to a rapid decay in the intracellular AC activity, implying that the invasive enzyme is unstable in the host cytoplasm. We report here that treatment of human lymphocytes with a glycolysis inhibitor and an uncoupler of oxidative phosphorylation completely blocked the intracellular inactivation of B. pertussis AC. Lymphocyte lysates inactivated all forms of B. pertussis AC in the presence of exogenous ATP. This inactivation was associated with degradation of an 'l25-labelled 200 kDa form of B. pertussis AC. It appears that ATP is required for the proteolytic pathway, but not as an energy source, since non-hydrolysable ATP analogues supported inactivation and complete degradation of the enzyme. The possibility that binding of ATP to B. pertussis AC renders it susceptible to degradation by the host cell protease is discussed.
INTRODUCTION
Bordetella pertussis, the causative agent of whooping cough, produces adenylate cyclase (AC) whose properties differ from those of other prokaryotic enzymes in being largely extracytoplasmic and stimulated by the eukaryotic Ca2l-binding protein, calmodulin (CaM) [1, 2] .
It is well documented that B. pertussis AC is capable of penetrating mammalian cells and generating high levels of cAMP within them [3] [4] [5] . In immune effector cells, the unregulated generation of cyclic AMP impairs functions such as chemotaxis, superoxide generation and microbial killing [6] . It was therefore suggested that B. pertussis AC acts as a toxin which suppresses host defences and assists the survival of the bacterium [6] . The importance of AC as a virulence factor was directly demonstrated by the findings that a transposon insertion mutant of B. pertussis deficient in AC was avirulent [7] .
Recently, several laboratories have described significant purification of B. pertussis AC. Ladant et al. [8] have purified the enzyme from bacterial culture medium; three structurally related catalysts [9] of molecular masses 43, 45 and 50 kDa were isolated. Rogel et al. [10] purified from extracts of concentrated bacterial cells two catalysts, of molecular masses 200 and 47 kDa, possessing immunologically related domains. Glaser et al. [11] have cloned and sequenced the B. pertussis gene for AC and showed that it has the potential to encode a very large polypeptide. Thus, the enzyme appears to be synthesized as a precursor of 200 kDa which is processed in the bacterium and secreted as lower molecular mass forms. The structure of the invasive form of the enzyme and whether it is delivered to target cells via direct contact with the bacterium or only after being released into the culture medium are not yet clear. The invasive form of the enzyme extracted from the bacteria migrated on gel filtration as a distinct minor peak of AC activity with apparent size of 190 kDa [4] . Immunoblot analysis of this form revealed the presence of a major catalyst of 200 kDa and in some preparations additional breakdown products of lower molecular mass [10] . Masure et al. [12] resolved from bacterial culture medium both invasive and non-invasive forms of B. pertussis AC. Only the invasive form displayed a Ca2l-dependent increase in its size. The catalysts purified from these two forms both had molecular masses of 45 kDa, but were [5, 13] . The constant level was maintained provided that the invasive enzyme was present in the medium. Upon transfer ofcells into enzyme-free medium, a rapid decrease in the intracellular AC activity was observed [5, 13] . This decrease reflected intracellular inactivation of the invasive enzyme and did not result from its release back to the medium. 
EXPERIMENTAL
Culture of organism and purification of B. pertussis AC B. pertussis strain 165 was grown in Stainer-Scholte liquid medium at 37°C as described previously [4] . The 47 kDa catalyst was purified according to the procedure of Rogel et al. [10] . The partially purified invasive form of AC was obtained by chromatography ofcrude dialysed urea extract of the bacteria on an Ultrogel AcA34 column as previously described [4, 10] . A 200 kDa catalyst was purified from this form essentially according to the procedure described [10] . The enzyme was loaded on CaM-agarose column in a solution containing 50 mmTris, pH 7.4/100 mM-NaCl/0.2 mM-CaCI2/2 M-urea. Then the column was washed with the following solutions: (1) 50 mM-Tris, pH 7.4/0.5 M-NaCl/0.2 mMCaCl2, (2) 50 mM-Tris, pH 7.4/2 mM-EGTA, (3) 50 mmTris, pH 7.4/0.2 mM-CaCl2. The elution was performed with a solution containing 50 mM-Tris, pH 7.4/0.2 mMCaCl2/8.8 M-urea. The hydroxylapatite chromatography was omitted and the eluent was dialysed against a buffer containing 50 mM-Tris, pH 7.4/0.2 mM-CaCl2 and concentrated by Amicon ultrafiltration using a PM-10 membrane. Bacillus anthracis Sterne strain was obtained from Dr. R. Tamarin, The Veterinary Institute, Beit Dagan, Israel. The Sterne strain was grown for 30 h at 36°C in defined medium as described by Ristroph & Ivins [16] . The culture supernatant was separated from the bacteria and used as a crude preparation of B. anthracis AC. Human lymphocytes and lymphocyte lysates Human lymphocytes were isolated from whole blood as described previously [4] . Lysates from untreated cells or cells pre-exposed to the invasive enzyme were prepared as follows. Cells [ (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) x 107] were suspended in 5 ml of lysing solution containing 20 mM-Hepes, pH 7.5/ 2 mM-MgCl2/2 mM-EDTA/2 mM-leupeptin/0. 15 mMpepstatin. The cells were then disrupted by freezing and thawing twice using liquid N2 followed by homogenization with a Dounce homogenizer using tightly fitted pestles. Nuclei and unbroken cells were removed by centrifugation at 900 g (IEC centrifuge) for 10 min. The lysate contained 1-2 mg of protein/ml and was stable for 14 days when kept frozen at -135 'C. Determination of the invasive-enzyme activity Lymphocytes were incubated with the invasive form of B. pertussis AC and the activity of the enzyme within the cells was determined after treatment of cells with trypsin as we have previously described [4, 5] . The intracellular decay in the activity of the invasive enzyme was monitored as explained previously [5, 13] [17] . The samples were boiled for 3 min and then subjected to polyacrylamide-gel electrophoresis (PAGE) in SDS followed by autoradiography as explained below. lodination and PAGE lodination of B. pertussis AC was conducted essentially according to the procedure of Ladant [9] . The 200 kDa catalyst was purified as explained above, and prior to its elution from the CaM-agarose column, 70 ,1 of packed resin was withdrawn and used for iodination. The iodinated catalyst was eluted and then passed through 10 ml of a Sephadex G-25 column equilibrated and run in a solution containing 50 mM-Tris, pH 7.5/0.1 mMCaCl2/0.1°% (w/v) NP-40 and 0.1 mg of bovine serum albumin ml-'. The activity of the iodinated catalyst was 0. I 0.2umol-min`1.0-I c.p.m. of 1251. PAGE was performed as described by Laemmli [17] . For visualization of the degradation products of 12511 labelled AC, the gels were fixed, dried and autoradiographed at -70°C for 1-12 h. For detection of AC activity in the gel, gel lanes were cut into 0.4 cm slices and the slices were treated with 2 % CHAPS solution as described by Masure et al. [12] . After renaturation, AC activity and radioactivity were determined. Other procedures AC activity of B: pertussis and of B. anthracis was determined in a total volume of 50,ul, and the assay mixture contained 50 mM-Hepes, pH 7.6/1 mM-[a-32P]-ATP/ 10 mM-MgCl2/60,uM-CaCl2/ 10 #uM-CaM . Crude preparations of plasma membranes from rat brain and human lymphocytes were prepared according to the procedures of Minocherhomjee et al. [18] and Ross et al. [19] respectively. The AC enzymes were preactivated by incubation of the membranes at 30°C for 20 min with 5 mM -MgCl2 /10 /M-guanosine 5'-[y -thio]triphosphate (GTP[S] ) and then extracted with 0.500 (w/v) Lubrol-PX as described [18] . The activities of the solubilized enzymes were determined in an assay mixture supplemented with 10 ,sM-forskolin, 10 ,M-CaM and 10 /LM-GTP[S] [19] . The results shown represent means of three determinations and the coefficient of variation did not exceed 10 %. The [32P]cAMP formed was isolated according to Salomon et al. [20] . Proteins were determined by the methods of Bradford [21] and Schaffner & Weissmann [22] . The levels of ATP in human lymphocytes before and after depletion were estimated by firefly luciferase assay [23] . (Fig. la) . Transfer of cells into medium containing glucose and adenine restored the intracellular ATP level as well as the penetration and the inactivation of the invasive enzyme (results not shown). Inactivation of B. pertussis AC in lysates of lymphocytes pre-exposed to the invasive enzyme could be restored by addition of exogenous ATP (Fig. lb) . Preliminary studies showed that the inactivation of B. pertussis AC by lymphocyte lysates occurred in the presence of millimolar concentrations of ATP and MgCl2. However, under these conditions, and at the concentrations of B. pertussis AC used, the ATP was rapidly depleted due to the conversion of ATP to cAMP, and therefore the inactivation reaction was stopped. We have found that the inactivation of B. pertussis AC also occur in the presence of micromolar concentrations of free MgCl2 and millimolar of the partially purified invasive form of B. pertussis AC. After 20 min, cells were washed and cell lysates were prepared as described in the Experimental section. The lysates obtained were reincubated at 36 0C in the presence (0) or absence (A) of 2 mM-ATP. At the indicated times, three samples of 10 ,ud each were withdrawn and AC activity was determined. 10000 represents the activity of the enzyme at time zero of the inactivation reaction, which Vol. 262 Fig. l(c) . Table 1 autoradiography. Zero time samples were incubated on ice with lymphocyte lysates 5-10 min before AC determinations and PAGE. We found that incubation of the enzyme with the lysates in the presence of ATP led to its rapid inactivation, whereas incubation of the enzyme with the lysates in the absence of ATP increased its activity by 1.5-2-fold (Fig. 2a) . This increase may be related to the decrease in the B. pertussis AC size. Rogel et al. [10] have found that the specific activity of the At the indicated times the AC activity was determined. 47 kDa fragment of B. pertussis AC was higher than that of the 200 kDa form of the enzyme. Autoradiography revealed that both in the absence and the presence of ATP the enzyme was degraded (Fig. 2b) . In the absence of ATP there was accumulation of a 42 kDa fragment which was resistant to further proteolysis (Fig. 2b) . In the presence of ATP the enzyme was completely degraded but tiny amounts of the 42 kDa a.-d other fragments could still be detected at zer'o time and after 5 min of incubation. A fragment of 160 kDa devoid of AC activity accumulated during degradation of the enzyme both in the presence and absence of ATP (Fig. 2b) . In order to determine whether the 42 kDa fragment generated in the absence of ATP was endowed with adenylate cyclase activity, the gel was sliced and each slice was extracted with 2 % (w/v) CHAPS and assayed for AC activity in the presence and absence of CaM. The peak of CaMstimulated AC activity migrated with apparent molecular mass of 42 kDa and corresponded exactly with the migration of the peak of '25I-labelled material, indicating that the 42 kDa fragment possesses both the catalytic and the CaM-binding sites (Fig. 3) . The activities of the same fractions assayed in the absence of CaM were at least 20-fold lower.
Nucleotide specificity of the activation process Several nucleotides were tested for their ability to support the proteolysis of B. pertussis AC. As shown in Table 2 , neither AMP, ADP, GTP nor CTP promoted inactivation of B. pertussis AC. In contrast, App[NH]p could induce inactivation and degradation of B. pertussis AC to a similar extent to ATP (Fig. 4) . In addition, both azJ-methylene ATP and fy-methylene ATP promoted inactivation of the enzyme (results not shown). However, Gpp[NH]p, GTP[S] and cAMP did not support degradation or loss of enzyme activity, and the 42 kDa active fragment was generated as was observed in the control (Fig. 4) Crude dialysed urea extract of concentrated B. pertussis bacteria was prepared as described in [10] . Crude preparations of AC from B. anthracis, rat brain and human lymphocytes were prepared as described in the Experimental section. Human lymphocyte lysates were pretreated with 5 mM-N-ethylmaleimide as explained in the legend to Fig. 3(a) . Leupeptin (2 mM), pepstatin (0.2 mM), PMSF (I mM) and TPCK (0.1 mM) were included in the inactivation mixture to prevent possible non-specific proteolysis. The inactivation was performed at 36°C and 100 % represents the activities of the various enzymes at zero time of inactivation. The specific activities of B. pertussis, B. anthracis, rat brain and human lymphocyte AC enzymes at zero time of the inactivation were 0.3jtmolImin-1 mg-1, 0.7,umol min-1 mg-1, 2nmol min-m -mg-' and 0.9 nmol min-1 mg-1 respectively. [25] , lost 80 % of its activity in the presence of ATP. The inactivation of B. anthracis AC also occurred in the absence of ATP, but at a slower rate. Neither 1251-labelled bovine serum albumin nor 125I-human chorionic gonadotropin, which served as arbitrary controls, were degraded under these conditions. Protease inhibitors such as PMSF (1 mM), leupeptin (2 mM), pepstatin (0.2 mM) TPCK (0.1 mM) and N-ethylmaleimide (5 mM) did not inhibit the inactivation or prevent the degradation of B. pertussis AC (Fig. 2) completely degraded and inactivated in the presence of millimolar concentrations of exogenous ATP. It appears that the degradation of the 200 kDa catalyst in the presence and the absence of ATP is conducted by the same protease(s). This conclusion is supported by the facts that (1) similar fragments are produced during degradation of the enzyme in the presence and absence of ATP (Figs. 2 and 4) , and (2) both degradation processes are unaffected by the same protease inhibitors or the presence of eukaryotic proteins. The notion that the degradation and inactivation of B. pertussis AC by lymphocyte lysates is related to the inactivation of the invasive enzyme observed within intact cells is suggested by the following findings. Depletion of ATP by metabolic inhibitors prevents the inactivation of the invasive AC in intact human lymphocytes and addition of exogenous ATP to lymphocyte lysates restores it. In addition, the kinetics of the enzyme inactivation both in lysates and intact cells fit a first-order reaction with half-life of 8-15 min. Direct demonstration that the invasive enzyme is inactivated by proteolysis in intact cells must wait until an invasive and labelled preparation of B. pertussis AC is available.
The mechanism by which ATP promotes inactivation of B. pertussis AC is not known. It is tempting to hyopthesize that ATP or ATP analogues bind to B. pertussis AC rendering the 42 kDa polypeptide susceptible to complete degradation, rather than acting by stimulation of an ATP-dependent protease. This hypothesis is supported by the following arguments. Usually, breakdown of proteins in mammalian and bacterial cells by ATP-dependent proteases requires hydrolysis of ATP and the presence. of millimolar concentrations of free Mg2" [26, 27] . In the case of B. pertussis AC, the degradation occurs in the presence of an excess of uncomplexed ATP and micromolar concentrations of free MgCl2. Under these conditions, the nucleotide is bound to the catalytic sites of AC but the production of cAMP is inhibited [28] . Furthermore, non-hydrolysable analogues ofATP such App[NH]p, and fly-methylene ATP promote the inactivation and degradation of the enzyme at similar efficiency as ATP. a,/-Methylene ATP, an analogue which is not converted to cAMP but is known to competitively inhibit AC activity [29] , promotes the inactivation of B. pertussis AC. NEthylmaleimide, which blocks ubiquitin-mediated proteolysis of proteins [30] , has no effect on the degradation of B. pertussis AC.
Although both B. pertussis and B. anthracis produce AC toxins with shared features, including activation by CaM and the ability to invade target cells, it appears that the anthrax AC enters cells by receptor-mediated endocytosis rather than by direct penetration of the plasma membrane [31] . Nevertheless, when anthraxtreated Chinese hamster ovary cells are placed in AC-free medium, a rapid decrease in level of cAMP is observed, suggesting that the internalized B. anthracis AC is unstable within the cytoplasm of the target cell [25] . We have shown that incubation of a crude preparation of B. anthracis AC with lymphocyte lysates led to a decay of enzyme activity which was enhanced by ATP. It is thus tempting to speculate that the same protease(s) found in the target cells is responsible for the inactivation of both types of invasive enzymes. Degradation of proteins in eukaryotic cells can be carried out by several different pathways [32] . Most of the work on protein breakdown has been performed either by using cell-free preparations [30] or by microinjection of radiolabelled proteins [33] . Although the exact pathway of B. pertussis AC degradation in the host has not been completely clarified, the study of B. pertussis inactivation has obvious advantages. It represents a system in which a toxic protein penetrates eukaryotic target cells wherein it is specifically inactivated and degraded. The structure of this protease, its cellular localization and its role in the inactivation of other toxins remain to be elucidated.
